Mariana Bastos, Hematologist at Hospital General Universitario Gregorio Marañón, Madrid, Spain, shared a post on X:
“Proud to share LATE-R interim results at EHA2026: the first prospective trial focused on late-relapsed LBCL treated with CAR-T. 90.4% CR at 3 months, supporting axi-cel as a highly effective option in this setting.”
Other articles about EHA2026 on OncoDaily.